Breaking News Instant updates and real-time market news.

LXFR

Luxfer

$14.42 /

+0.67 (+4.87%)

16:38
04/27/20
04/27
16:38
04/27/20
16:38

Luxfer reports Q1 adjusted EPS 30c, consensus 26c

Reports Q1 revenue $103.8M, consensus $101.7M. "During this unprecedented time, our priority is safeguarding our employees and serving our customers to ensure business continuity," stated Luxfer's Chief Executive Officer, Alok Maskara. "Luxfer's first quarter results reflect the global macro environment of the COVID-19 pandemic. Our business saw pockets of growth, but they were offset by broad-based market weakness. While the macro environment remains challenging, we continue to make strong progress on our transformation plan, including the $1 million of first quarter net cost reductions. We remain focused on achieving our cost savings initiatives and are in constant communication with our customers, to prepare for a return to growth and higher profitability when conditions improve."

  • 28

    Apr

  • 05

    May

LXFR Luxfer
$14.42 /

+0.67 (+4.87%)

04/23/20 B. Riley
Luxfer price target lowered to $19 from $25 at B. Riley FBR
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Luxfer initiated with a Buy at Roth Capital
11/19/19 B. Riley
Luxfer initiated with a Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Hot Stocks
vTv Therapeutics receives breakthrough therapy designation for TTP399 from FDA » 07:31
04/13/21
04/13
07:31
04/13/21
07:31
VTVT

vTv Therapeutics

$2.58 /

-0.17 (-6.18%)

vTv Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

Recommendations
Square price target raised to $310 from $300 at Needham » 07:31
04/13/21
04/13
07:31
04/13/21
07:31
SQ

Square

$265.25 /

+3.485 (+1.33%)

Needham analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

04/09/21 Credit Suisse
Square price target raised to $290 from $270 at Credit Suisse
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Oddo BHF
Square initiated with a Neutral at Oddo BHF
04/07/21 Barclays
Barclays boosts Square target to $330 on potential for international upside
SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

Initiation
SunOpta initiated with a Buy at Canaccord » 07:29
04/13/21
04/13
07:29
04/13/21
07:29
STKL

SunOpta

$15.02 /

+0.13 (+0.87%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STKL SunOpta
$15.02 /

+0.13 (+0.87%)

STKL SunOpta
$15.02 /

+0.13 (+0.87%)

03/04/21 Craig-Hallum
SunOpta price target raised to $25 from $15 at Craig-Hallum
02/03/21 Lake Street
SunOpta price target raised to $18 from $15 at Lake Street
12/10/20 Craig-Hallum
SunOpta initiated with a Buy at Craig-Hallum
12/09/20 Lake Street
SunOpta price target raised to $15 from $9 at Lake Street
STKL SunOpta
$15.02 /

+0.13 (+0.87%)

STKL SunOpta
$15.02 /

+0.13 (+0.87%)

Recommendations
JD.com price target lowered to $90 ahead of earnings at Morgan Stanley » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
JD

JD.com

$78.68 /

-1.71 (-2.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

03/12/21 HSBC
JD.com price target raised to $108 from $103 at HSBC
03/12/21 UBS
JD.com price target raised to $110 from $105 at UBS
03/12/21 Citi
JD.com price target raised to $120 from $117 at Citi
01/27/21 Macquarie
JD.com price target raised to $133 from $107 at Macquarie
JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

Downgrade
Aphria downgraded to Hold on industry headwinds at Canaccord » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
APHA

Aphria

$13.93 /

-2.34 (-14.38%)

, TLRY

Tilray

$17.15 /

-2.62 (-13.25%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

06:31 Today Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
04/12/21 Alliance Global Partners
Alliance Global trims Aphria price target to C$24, says long-term view intact
04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
TLRY Tilray
$17.15 /

-2.62 (-13.25%)

04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/18/21
Fly Intel: Top five analyst downgrades
02/18/21 Roth Capital
Tilray price target raised to $25 from $10 at Roth Capital
APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

Downgrade
Cadence Bancorp downgraded to Hold from Buy at Truist » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
CADE

Cadence Bancorp

$22.41 /

+0.92 (+4.28%)

, BXS

BancorpSouth

$30.45 /

-1.79 (-5.55%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

06:37 Today Raymond James
Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James
06:10 Today RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
04/12/21 RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
02/23/21 Stephens
Stephens raises Regions price target to $23, sees possible deal for Cadence
BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

06:10 Today RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
12/03/20 Stephens
National United deal shouldn't preclude more M&A at BancorpSouth, says Stephens
11/16/20 DA Davidson
BancorpSouth downgraded to Neutral from Buy at DA Davidson
11/16/20 DA Davidson
BancorpSouth downgraded to Neutral from Buy at DA Davidson
CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

General news
European stock markets are mostly higher, » 07:25
04/13/21
04/13
07:25
04/13/21
07:25
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Conference/Events
    Immunocore to host conference call » 07:25
    04/13/21
    04/13
    07:25
    04/13/21
    07:25
    IMCR

    Immunocore

    $32.22 /

    -3.28 (-9.24%)

    Management discusses…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    03/02/21 Jefferies
    Immunocore initiated with a Buy at Jefferies
    03/02/21 JPMorgan
    Immunocore initiated with an Overweight at JPMorgan
    03/02/21 Goldman Sachs
    Immunocore initiated with a Neutral at Goldman Sachs
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    • 05
      Feb
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    Conference/Events
    Auris Medical to host business news update conference call » 07:25
    04/13/21
    04/13
    07:25
    04/13/21
    07:25
    EARS

    Auris Medical

    $4.26 /

    -0.015 (-0.35%)

    Management provides a…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    Syndicate
    TripAdvisor announces pricing of Global Offering » 07:24
    04/13/21
    04/13
    07:24
    04/13/21
    07:24
    TRIP

    TripAdvisor

    $51.17 /

    -1.27 (-2.42%)

    announced the pricing of…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    07:10 Today Jefferies
    TripAdvisor price target raised to $29 from $24 at Jefferies
    04/05/21 Evercore ISI
    TripAdvisor assumed with an In Line at Evercore ISI
    03/31/21 Wolfe Research
    TripAdvisor initiated with a Peer Perform at Wolfe Research
    03/12/21 Truist
    TripAdvisor price target raised to $62 from $48 at Truist
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    Upgrade
    Ameren upgraded to Buy from Neutral at BofA » 07:24
    04/13/21
    04/13
    07:24
    04/13/21
    07:24
    AEE

    Ameren

    $80.70 /

    +0.15 (+0.19%)

    BofA analyst Julien…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    07:01 Today BofA
    Ameren upgraded to Buy from Neutral at BofA
    04/08/21 Mizuho
    Ameren initiated with a Neutral at Mizuho
    11/18/20 Barclays
    Ameren upgraded to Equal Weight from Underweight at Barclays
    09/21/20 Barclays
    Ameren downgraded to Underweight from Equal Weight at Barclays
    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    Initiation
    B. Riley starts GT Biopharma with Buy, sees 101% upside in shares » 07:22
    04/13/21
    04/13
    07:22
    04/13/21
    07:22
    GTBP

    GT Biopharma

    $10.29 /

    -0.1 (-0.96%)

    B. Riley analyst Justin…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GTBP GT Biopharma
    $10.29 /

    -0.1 (-0.96%)

    GTBP GT Biopharma
    $10.29 /

    -0.1 (-0.96%)

    04:47 Today B. Riley
    GT Biopharma initiated with a Buy at B. Riley
    03/17/21 Roth Capital
    GT Biopharma initiated with a Buy at Roth Capital
    • 11
      Feb
    Recommendations
    Cleveland-Cliffs price target raised to $22 from $21 at B. Riley » 07:20
    04/13/21
    04/13
    07:20
    04/13/21
    07:20
    CLF

    Cleveland-Cliffs

    $17.54 /

    -0.285 (-1.60%)

    B. Riley analyst Lucas…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    04/09/21 Goldman Sachs
    Cleveland-Cliffs initiated with a Neutral at Goldman Sachs
    03/31/21 B. Riley Securities
    Cleveland-Cliffs price target raised to $21 from $20 at B. Riley Securities
    02/03/21 Credit Suisse
    U.S. Steel Industry upgraded to Overweight at Credit Suisse
    01/26/21 GLJ Research
    Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    • 09
      Feb
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    Syndicate
    Chewy 6.1M share Block Trade priced at $82.50 » 07:19
    04/13/21
    04/13
    07:19
    04/13/21
    07:19
    CHWY

    Chewy

    $84.02 /

    +0.03 (+0.04%)

    Morgan Stanley acted as…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    04/05/21 Evercore ISI
    Chewy assumed with an Outperform at Evercore ISI
    03/31/21 Wolfe Research
    Chewy initiated with a Peer Perform at Wolfe Research
    03/31/21 Wedbush
    Chewy price target raised to $100 from $90 at Wedbush
    03/31/21 Jefferies
    Chewy price target raised to $105 from $100 at Jefferies
    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    • 20
      Apr
    • 17
      Sep
    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    CHWY Chewy
    $84.02 /

    +0.03 (+0.04%)

    Initiation
    B. Riley starts Identiv at Buy, sees 82% upside in shares » 07:18
    04/13/21
    04/13
    07:18
    04/13/21
    07:18
    INVE

    Identiv

    $11.75 /

    +0.25 (+2.17%)

    B. Riley analyst Craig…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    INVE Identiv
    $11.75 /

    +0.25 (+2.17%)

    INVE Identiv
    $11.75 /

    +0.25 (+2.17%)

    04/12/21 B. Riley
    Identiv initiated with a Buy at B. Riley
    09/28/20 Northland
    Identiv benefitting as Apple supports NFC, says Northland
    09/22/20 Lake Street
    Identiv price target raised to $8 after management meeting at Lake Street
    INVE Identiv
    $11.75 /

    +0.25 (+2.17%)

    • 08
      Apr
    Hot Stocks
    Lithia Motors acquires The Suburban Collection in Troy, Michigan » 07:17
    04/13/21
    04/13
    07:17
    04/13/21
    07:17
    LAD

    Lithia Motors

    $402.26 /

    +3.81 (+0.96%)

    Lithia Motors announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    LAD Lithia Motors
    $402.26 /

    +3.81 (+0.96%)

    LAD Lithia Motors
    $402.26 /

    +3.81 (+0.96%)

    03/11/21 Craig-Hallum
    Lithia Motors price target raised to $500 from $450 at Craig-Hallum
    02/24/21 Citi
    Lithia Motors price target raised to $385 from $320 at Citi
    02/10/21
    Fly Intel: Top five analyst downgrades
    02/10/21 Morgan Stanley
    Morgan Stanley cuts Lithia Motors to sell with shares near bull case
    LAD Lithia Motors
    $402.26 /

    +3.81 (+0.96%)

    • 01
      Oct
    LAD Lithia Motors
    $402.26 /

    +3.81 (+0.96%)

    Hot Stocks
    Extreme Networks appoints John Abel as CIO » 07:15
    04/13/21
    04/13
    07:15
    04/13/21
    07:15
    EXTR

    Extreme Networks

    $9.47 /

    +0.06 (+0.64%)

    Extreme Networks…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    EXTR Extreme Networks
    $9.47 /

    +0.06 (+0.64%)

    EXTR Extreme Networks
    $9.47 /

    +0.06 (+0.64%)

    02/24/21 Lake Street
    Extreme Networks price target raised to $12 from $8 at Lake Street
    02/10/21 B. Riley Securities
    Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities
    01/28/21 Lake Street
    Extreme Networks price target raised to $8 from $6 at Lake Street
    01/28/21 B. Riley Securities
    Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities
    EXTR Extreme Networks
    $9.47 /

    +0.06 (+0.64%)

    EXTR Extreme Networks
    $9.47 /

    +0.06 (+0.64%)

    Hot Stocks
    J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use  07:15
    04/13/21
    04/13
    07:15
    04/13/21
    07:15
    JNJ

    Johnson & Johnson

    $161.62 /

    +0.42 (+0.26%)

     
    ShowHide Related Items >><<
    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    04/01/21 Piper Sandler
    Integra to benefit from FDA safety communication, says Piper Sandler
    02/10/21 BTIG
    Model N upgraded to Buy from Neutral at BTIG
    02/01/21 SVB Leerink
    Moderna price target raised to $80 from $69 at SVB Leerink
    02/01/21 Wells Fargo
    Moderna price target raised to $145 from $129 at Wells Fargo
    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    Hot Stocks
    FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine » 07:14
    04/13/21
    04/13
    07:14
    04/13/21
    07:14
    JNJ

    Johnson & Johnson

    $161.62 /

    +0.42 (+0.26%)

    In a series of tweets,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    04/01/21 Piper Sandler
    Integra to benefit from FDA safety communication, says Piper Sandler
    02/10/21 BTIG
    Model N upgraded to Buy from Neutral at BTIG
    02/01/21 SVB Leerink
    Moderna price target raised to $80 from $69 at SVB Leerink
    02/01/21 Wells Fargo
    Moderna price target raised to $145 from $129 at Wells Fargo
    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    JNJ Johnson & Johnson
    $161.62 /

    +0.42 (+0.26%)

    Initiation
    Lumos Pharma initiated with a Buy at JonesTrading » 07:13
    04/13/21
    04/13
    07:13
    04/13/21
    07:13
    LUMO

    Lumos Pharma

    $10.99 /

    -0.32 (-2.83%)

    JonesTrading analyst Lina…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    LUMO Lumos Pharma
    $10.99 /

    -0.32 (-2.83%)

    LUMO Lumos Pharma
    $10.99 /

    -0.32 (-2.83%)

    03/11/21 Stifel
    Lumos Pharma upgraded to Buy from Hold at Stifel
    12/03/20
    Fly Intel: Top five analyst initiations
    12/03/20 Cantor Fitzgerald
    Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
    12/02/20 Cantor Fitzgerald
    Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
    LUMO Lumos Pharma
    $10.99 /

    -0.32 (-2.83%)

    LUMO Lumos Pharma
    $10.99 /

    -0.32 (-2.83%)

    Hot Stocks
    MEI Pharma completes enrollment in Phase 2 Tidal study » 07:12
    04/13/21
    04/13
    07:12
    04/13/21
    07:12
    MEIP

    MEI Pharma

    $3.39 /

    -0.04 (-1.17%)

    MEI Pharma and Kyowa…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MEIP MEI Pharma
    $3.39 /

    -0.04 (-1.17%)

    MEIP MEI Pharma
    $3.39 /

    -0.04 (-1.17%)

    10/12/20 Brookline
    MEI Pharma initiated with a Buy at Brookline
    09/22/20 Alliance Global Partners
    MEI Pharma initiated with a Buy at Alliance Global Partners
    07/06/20 SunTrust
    MEI Pharma price target lowered to $12 from $16 at SunTrust
    05/29/20
    Fly Intel: Top five analyst initiations
    MEIP MEI Pharma
    $3.39 /

    -0.04 (-1.17%)

    MEIP MEI Pharma
    $3.39 /

    -0.04 (-1.17%)

    Recommendations
    Nvidia price target raised to $700 from $620 at Credit Suisse » 07:12
    04/13/21
    04/13
    07:12
    04/13/21
    07:12
    NVDA

    Nvidia

    $608.46 /

    +33.14 (+5.76%)

    Credit Suisse analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    07:08 Today Deutsche Bank
    Nvidia price target raised to $575 from $560 at Deutsche Bank
    06:57 Today Mizuho
    Nvidia price target raised to $675 from $650 at Mizuho
    06:56 Today Susquehanna
    Nvidia to invest heavily into data center space, says Susquehanna
    06:09 Today Barclays
    Nvidia price target raised to $650 from $600 at Barclays
    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    NVDA Nvidia
    $608.46 /

    +33.14 (+5.76%)

    Upgrade
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11
    04/13/21
    04/13
    07:11
    04/13/21
    07:11
    BMY

    Bristol-Myers

    $62.70 /

    +0.09 (+0.14%)

    As previously reported,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    06:08 Today Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    04/12/21 B. Riley
    B. Riley calls Agenus the next Seagen, reiterates $8 target
    03/08/21 BofA
    Gartner added to US 1 List, Bristol-Myers removed at BofA
    02/12/21 Morgan Stanley
    Amgen court decision may have readthrough for Gilead, says Morgan Stanley
    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    BMY Bristol-Myers
    $62.70 /

    +0.09 (+0.14%)

    Recommendations
    TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10
    04/13/21
    04/13
    07:10
    04/13/21
    07:10
    TRIP

    TripAdvisor

    $51.17 /

    -1.27 (-2.42%)

    Jefferies analyst Brent…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    04/05/21 Evercore ISI
    TripAdvisor assumed with an In Line at Evercore ISI
    03/31/21 Wolfe Research
    TripAdvisor initiated with a Peer Perform at Wolfe Research
    03/12/21 Truist
    TripAdvisor price target raised to $62 from $48 at Truist
    03/02/21 Citi
    TripAdvisor upgraded to Buy from Neutral at Citi
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    Hot Stocks
    Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10
    04/13/21
    04/13
    07:10
    04/13/21
    07:10
    BHC

    Bausch Health

    $29.93 /

    -0.86 (-2.79%)

    Bausch + Lomb, a global…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BHC Bausch Health
    $29.93 /

    -0.86 (-2.79%)

    BHC Bausch Health
    $29.93 /

    -0.86 (-2.79%)

    03/24/21
    Fly Intel: Top five analyst downgrades
    03/24/21 BofA
    BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection'
    03/24/21 BofA
    Bausch Health downgraded to Underperform from Neutral at BofA
    03/16/21 H.C. Wainwright
    Bausch Health price target raised to $55 from $50 at H.C. Wainwright
    BHC Bausch Health
    $29.93 /

    -0.86 (-2.79%)

    BHC Bausch Health
    $29.93 /

    -0.86 (-2.79%)

    BHC Bausch Health
    $29.93 /

    -0.86 (-2.79%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.